Metastatic or locally advanced breast cancer patients: towards an expert consensus on nab-paclitaxel treatment in HER2-negative tumours—the MACBETH project-Reference-Cited by-同舟云学术

Metastatic or locally advanced breast cancer patients: towards an expert consensus on nab-paclitaxel treatment in HER2-negative tumours—the MACBETH project

Published:2018-11-20 Issue:2 Volume:83 Page:301-318
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Cazzaniga Marina E., ,Ciruelos E.,Fabi A.,Garcia-Saenz J.,Lindman H.,Mavroudis D.,Schem C.,Steger G.,Timotheadou E.,Zaman K.,Torri V.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/article/10.1007/s00280-018-3717-2/fulltext.html

Reference41 articles.

1. Gelderblom H, Verweij J, Nooter K, Sparreboom A (2001) Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer Oxf Engl 1990 37(13):1590–1598

2. Nyman DW et al (2005) Phase I and pharmacokinetics trial of ABI-007, a novel nanoparticle formulation of paclitaxel in patients with advanced nonhematologic malignancies. J Clin Oncol 23(31):7785–7793

3. Gradishar WJ et al (2005) Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J Clin Oncol 23(31):7794–7803

4. Gradishar WJ et al (2009) Significantly longer progression-free survival with nab-paclitaxel compared with docetaxel as first-line therapy for metastatic breast cancer. J Clin Oncol 27(22):3611–3619

5. Bernardo A et al (Oct. 2017) Nab-paclitaxel in advanced HER2-negative breast cancer patients: efficacy and safety beyond clinical trials. Clin Breast Cancer 17(6):433–440

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta-analysis of nab-paclitaxel mono-chemotherapy for metastatic breast cancer;BMC Cancer;2021-07-18